Kaan Certel

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Barbara Chan, Attorney-in-Fact for Kaan Certel
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kaan Certel:

Company Role Class Num Shares Value Price $ Report Date Ownership
Omega Therapeutics, Inc. President and Chief Executive Officer, Director Stock Option (Right to Buy) 340,000 15 Nov 2024 Direct

Insider Reports Filed by Kaan Certel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OMGAQ Omega Therapeutics, Inc. 15 Nov 2024 1 $0 4 President and Chief Executive Officer, Director 15 Nov 2024, 18:09
OMGAQ Omega Therapeutics, Inc. 31 May 2024 1 $0 4 Chief Business Officer 31 May 2024, 16:57
OMGAQ Omega Therapeutics, Inc. 28 May 2024 0 $0 3 Chief Business Officer 31 May 2024, 16:50